IDIX Related Earnings News
-
Vertex (VRTX) VX-135 Looks Interesting, Thinks Deutsche Bank
-
Idenix Pharmaceuticals (IDIX) Reports In-Line Q4 Loss of 17c/Share
-
Idenix Pharmaceuticals (IDIX) Tops Q3 EPS by 20c
-
Barclays Lowers Outlook on Idenix Pharmaceuticals (IDIX); Clarity on FDA Clinical Hold (BMY, VRTX, GILD)
-
Brean Murray Carret & Co. Upgrades Idenix Pharmaceuticals Inc. (IDIX) to Hold; IDX184 on Clinical Hold Again
-
Wedbush Raises Price Target on Idenix Pharmaceuticals (IDIX) Following Pipeline Update
-
Idenix Pharmaceuticals (IDIX) Posts Q4 Loss of 18c/Sh., Wider than Views
-
Idenix Pharmaceuticals, Inc. (IDIX) Reports Q3 Loss of 12c
-
Idenix Pharmaceuticals, Inc. (IDIX) Posts Q2 EPS Loss of $0.15, Revenues Miss Expectations
-
Idenix Pharmaceuticals Inc. (IDIX) Posts Narrower than Expected Q1 Loss
-
Idenix Pharma (IDIX) Posts Wider than Expected Q4 Loss
-
Idenix Pharma (IDIX) Reports Better-Than-Expected Q3 Loss of 18c
-
Idenix Pharma (IDIX) Misses Q1 Street Views
-
Idenix Pharma (IDIX) Posts Q4 Loss of $0.19, In-Line with Views
-
Idenix Pharma (IDIX) Announces Progress in Three HCV Programs; Updates on FY09 Guidance
-
Idenix Pharmaceuticals (IDIX) Tops Q3 EPS by 6c; Retains Worldwide Rights to Develop and Commercialize IDX184
-
Idenix Pharmaceuticals (IDIX) Misses Q2 View By 3c
-
Idenix Pharma (IDIX) Reports Better-Than Expected Q4 Loss of $0.25
-
Idenix Pharmaceuticals (IDIX) Tops Q3 EPS By 4c
-
Idenix Pharmaceuticals (IDIX) Tops Q4 View
-
Idenix Pharmaceuticals (IDIX) Reports Q3 Loss of ($0.54)
-
Idenix Pharmaceuticals (IDIX) Misses Q4 EPS by 8c, Guides Below for FY
-
Idenix Pharmaceutical (IDIX) option implied volatility above average on light Volume
Back to IDIX Stock Lookup
